Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae661Source: DataRank Database

Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: bronzeTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Edna E. Mancilla,Michael A. Levine ORCID,M. Mayer ORCID,Heather M. Monk ORCID,Joseph Rosano

Live enrichment

PubMed:39324646 PMC:PMC12187120 OpenAlex:https://openalex.org/W4402865766

CHOP Research Institute

Grant: T32DK063688

National Institute of Diabetes and Digestive and Kidney Diseases to CHOP

Children’s Hospital of Philadelphia Research Instiute

NIH HHS

FWCI

0.00

Citation Percentile

0.2%

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://academic.oup.com/jcem/article-pdf/110/7/2031/59760958/dgae661.pdf

publisherhttps://academic.oup.com/jcem/article-pdf/110/7/2031/59760958/dgae661.pdf

publisherhttps://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgae661/59760958/dgae661.pdf

journalhttps://doi.org/10.1210/clinem/dgae661

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39324646

Fields of Study

Bone health and osteoporosis researchBone health and treatmentsBone fractures and treatmentsHumansZoledronic AcidChildMaleRetrospective StudiesFemaleAdolescentBone Density Conservation AgentsBone DensityYoung AdultChild, PreschoolAbsorptiometry, PhotonInfantFractures, BoneTreatment OutcomeInfant, Newborn

MeSH Terms

Zoledronic AcidAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleRetrospective StudiesAbsorptiometry, PhotonBone DensityTreatment OutcomeBone Density Conservation AgentsFractures, BoneYoung Adult

Keywords

MedicineBone mineralContext (archaeology)Fragility fractureRetrospective cohort studyZoledronic acidCohortBone densityPopulationInternal medicineFragilityOsteoporosisBisphosphonateZoledronic Acid (Za)Fracture Rate (Fx Rate)